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Introduction
The signal transducer and activator of transcription (STAT) 
proteins are a family of transcription factors which have been 
shown to be involved in many cellular functions including 
tumorigenesis, apoptosis, cell proliferation, development, and 
autophagy.1-10 Following activation, STAT1 and 3 are tyrosine 
phosphorylated and dimerize after which they are translocated to 
the nucleus. During nuclear translocation, they are phosphory-
lated at a serine residue located in the C-terminal transactivation 
domain which is thought to enhance transcriptional activity of 
the complex.11
Cardiac ischemia/reperfusion (I/R) injury results from the 
occlusion of blood flow through the coronary arteries lead-
ing to cell death in the ventricle of the heart by apoptosis and 
necrosis which leads to a decreased cardiac output and can 
result in heart failure.12,13 STAT1 and 3 have been shown to 
be closely linked during cardiac I/R injury showing oppos-
ing mechanisms of action while STAT3 has been shown to be 
located in the mitochondria and is thought to be involved in 
modulating the mitochondrial permeability transition pore.14 
STAT1, specifically the C-terminus, has been shown to be 
involved in promoting apoptotic cell death leading to increased 
infarct size.15-17 The activation of STAT1 during I/R injury is 
likely to be augmented by the generation of free-radicals from 
uncoupling of oxidative phosphorylation at the mitochondria. 
The signal transducer and activator of transcription (STAT) proteins are latent transcription factors that have been 
shown to be involved in cell proliferation, development, apoptosis, and autophagy. STAT proteins undergo activation 
by phosphorylation at tyrosine 701 and serine 727 where they translocate to the nucleus to regulate gene expression. 
STAT1 has been shown to be involved in promoting apoptotic cell death in response to cardiac ischemia/reperfusion 
and has recently been shown by our laboratory to be involved in negatively regulating autophagy. These processes are 
thought to promote cell death and restrict cell survival leading to the generation of an infarct. here we present data 
that shows STAT1 localizes to the mitochondria and co-immunoprecipitates with Lc3. Furthermore, electron microscopy 
studies also reveal mitochondria from ex vivo I/R treated hearts of STAT1KO mice contained within a double membrane 
autophagosome indicating that STAT1 may be involved in negatively regulating mitophagy. This is the first description of 
STAT1 being localized to the mitochondria and also having a role in mitophagy.
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Indeed, data from our laboratory using an in vivo rat model of 
I/R injury showed that free-radical scavenging using the drug 
4-hydroxytempol, showed marked decrease in infarct size with 
concomitant inhibition of STAT1 phosphorylation.18 Further 
ex vivo studies using STAT1 knockout animals subjected to 
I/R injury also showed reduced infarct size further suggesting 
that STAT1 was an important protein for apoptotic cell death.19 
Inhibition of STAT1 phosphorylation using the polyphenolic, 
green tea extract epigallocatechin-3-gallate in both in vitro and 
ex vivo studies revealed increased cardiomyocyte survival lead-
ing to improved hemodynamic ventricular function and hemo-
dynamic recovery.20
Autophagy is a catabolic process that involves enveloping 
cellular material with a double membrane vesicle (the autopha-
gosome) in order to generate ATP.21 The formation of the 
autophagosome begins with the mammalian target of rapamy-
cin (mTOR) which modulates the initiator protein Ulk1.22 
The Bcl-2 and Bcl-XL proteins inhibit nucleation by binding 
to Beclin-1, which becomes phosphorylated by DAP-Kinase 
resulting in the association of ATG-14, VPS-34, and VPS-15 
with Beclin-1, which leads to the association and activation of 
elongation and maturation of the autophagosome.23-25 The sig-
naling involved in elongation and maturation is complex, but 
ultimately leads to the lipidation of microtubule-associated pro-
tein 1 light chain 3 (MAP-LC3) from LC3-I to LC3-II. Kabeya 
and colleagues showed that LC3-II appeared to associate with 
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Mitochondria constitute around 30% of 
cardiomyocyte cell volume and supply the 
contracting heart with the ATP required for 
sustained contraction.28 However, the onset of 
reperfusion results in the generation of highly 
reactive oxygen free radicals, or superoxide, 
which are responsible for much of the cellular 
damage during injury and which have been 
shown to induce necrosis and apoptosis.29,30 
It was initially thought that autophagy was 
a non-selective process; however, recent data 
suggests that autophagy selectively degrades 
cellular material.28 Indeed, to limit the dam-
age inflicted by oxidative-phosphorylation 
uncoupling, damaged mitochondria are selec-
tively sequestered for degradation by mitoph-
agy or mitochondrial autophagy which may 
contribute to cell survival and ultimately 
improved cardiac function.31 Here we show 
for the first time by immunofluorescence 
and subcellular fractionation, that STAT1 is 
localized to the mitochondria following I/R 
injury and using co-immunoprecipitation 
we further show that STAT1 binds to the 
autophagic marker, LC3. Taken together, we 
present data which suggests that STAT1 may 
be involved in regulating the selective deg-
radation of mitochondria by the autophagic 
pathway or mitophagy.
Results
STAT1 localizes to the mitochondria fol-
lowing simulated ischemia/reperfusion injury
Previous reports have shown that STAT3 
localizes to the mitochondrial membrane 
where it is thought to be involved in the modu-
lation of oxidative-phosphorylation.32 Since 
STAT1 and 3 often have antagonistic effects 
we postulated that STAT1 may also reside in/
at the mitochondria. Here we show for the first 
time that STAT1 localizes to the mitochon-
dria following simulated ischemia/reperfusion 
injury. Under control conditions, it could be 
seen that STAT1 localized to the mitochon-
dria, however, following simulated I/R injury this localization 
appeared more punctate (Fig. 1A).
Primary cardiac myocytes were cultured under normoxic 
conditions for 48 h following isolation, and the media was 
then replaced with ischemic buffer and the cells subjected 
to four hours of simulated ischemia and 24 h of reperfusion. 
Mitochondria were stained with Mitotracker-Red (Molecular 
Probes) and the cells fixed with 4% (w/v) paraformaldehyde for 
15 min then stained with anti-STAT1 or anti-STAT3 antibod-
ies. As shown in Figure 1A, STAT1 was found to form punc-
tate staining where STAT1 co-localized with mitochondria. We 
the autophagosome membrane and shares 28% homology with 
yeast Apg8/Aug7p which has been shown to be important in 
yeast autophagosome formation.26,27
Studies have shown that during I/R injury, autophagy is acti-
vated and is thought to promote cell survival and reduce infarct 
size. Studies from our laboratory have shown that STAT1, as 
well as promoting apoptosis, negatively regulates autophagy.19 
We propose that by enhancing apoptosis and negatively regulat-
ing autophagy, STAT1 promotes the generation of larger infarcts 
which can lead to heart failure. Recently, another catabolic cel-
lular process, mitophagy, has received much attention.
Figure 1. primary cardiomyocytes were seeded onto gelatin coated-glass coverslips and 
subjected to normoxic (control) conditions or simulated ischemia/reperfusion injury, stained 
with 25 nM Mitotracker-Red then fixed with 4% paraformaldehyde. Immunofluorescent 
staining indicated that STAT1 co-localized to the mitochondria before I/R injury but formed 
more localized, punctate staining following I/R injury (A) while STAT3, formed localized 
punctate staining both before and after I/R injury (B). In order to confirm the presence of 
STAT1 in the mitochondrial fraction, subcellular fractionation of primary cardiac fibroblasts 
under normoxic conditions was performed and the mitochondrial (M), cytosolic (c) and 
nuclear (N) fractions run on 10% pAGe gels and western blotting indicated the presence of 
STAT1 in all three fractions (C). In order to ensure that the presence of STAT1 was not due to 
contamination, the blots were interrogated for the cytosolic marker, GApDh and the mito-
chondrial membrane marker, coxIV (C).
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injury as described above and the mitochondrial and cytosolic 
fractions isolated. Western blotting of these fractions and inter-
rogated for STAT1 and STAT3 revealed that both STAT1 and 
STAT3 appeared to move from the mitochondrial fraction into 
the cytosolic fraction following simulated I/R injury (Fig. 3C).
Discussion
It has been known for quite some time that autophagy occurs 
in the heart and has been shown in vitro and in ex vivo.38-40 The 
first description of mitophagy in the heart was by Decker and 
Wildenthal, although the mechanisms of mitophagy still remain 
unclear.39 We recently reported that STAT1 was involved in 
negatively regulating autophagy as seen in the Langendorff per-
fused STAT1−/− heart.19 Our electron microscopy data revealed 
increased numbers of autophagic bodies containing damaged 
mitochondria in the STAT1−/− animals compared with their wild-
type littermate controls. These data led us to believe that, in fact, 
STAT1 may also be responsible for regulating mitophagy.
Mitochondria are responsible for generating the large con-
centrations of ATP required for sustained heart contraction.28 
However, during I/R injury oxidative phosphorylation becomes 
uncoupled and highly active superoxide anions begin to “leak” 
causing damage to cellular proteins and organelles.41,42 Studies 
have shown that the re-establishment of blood flow leads to 
additional free-radical generation which ultimately leads to fur-
ther damage.13 We and others have shown that scavenging free 
radicals using compounds such as 4-hydroxy-tempol, during 
the reperfusion phase of injury results in an increase in cell sur-
vival as shown by decreased infarct size and inhibition of STAT1 
phosphorylation.18,43
The role of autophagy by the catabolism of cellular mate-
rial to generate ATP for cell survival has been known for quite 
some time, as has the process of mitophagy.44,45 However, it 
was initially thought that mitophagy was an almost acciden-
tal/non-selective process.28 Recently, it has been suggested that 
the process of mitophagy may indeed be a very deliberate pro-
cess in order to remove damaged mitochondria and facilitate 
cell survival.28 Indeed, two different pathways are involved in 
found that under the conditions described here, STAT1 mito-
chondrial localization was more obvious than STAT3 mito-
chondrial localization (Fig. 1B).
To further analyze the presence of STAT1 at the mitochon-
dria, we performed subcellular fractionation studies on primary 
cardiac fibroblasts under normoxic conditions. Fibroblasts from 
the primary neonate isolation were cultured in DMEM con-
taining 10% FBS until 90% confluent and then subjected to 
subcellular fractionation. The mitochondrial, nuclear and 
cytosolic fractions were run on 10% denaturing PAGE gels and 
western blotting performed. Here we found a strong presence 
of STAT1 in the mitochondrial and cytosolic fractions but only 
a small amount in the nuclear fraction. In order to confirm 
that the presence of STAT1 was not due to contamination, we 
performed western blotting for the mitochondrial membrane 
marker Cox IV and the cytosolic marker glyceraldehyde-
6-phosphate dehydrogenase (GAPDH). As shown in Figure 
1C, no contamination of GAPDH was seen in the mitochon-
drial fraction and no Cox IV contamination was found in the 
mitochondrial fraction. These data, together with the immu-
nofluorescence results suggest that STAT1 is localized to the 
mitochondria.
Enhanced mitophagy occurs in STAT1−/− mice subjected to 
ex vivo ischemia/reperfusion injury
STAT1−/− and wild-type littermate controls were subjected to 
ex vivo Langendorff perfusion as previously described.19 Using 
electron microscopy we found that in STAT1−/− animals showed 
increased numbers of mitochondria enveloped in double mem-
brane structures suggesting that mitochondria were undergoing 
selective degradation by mitophagy (Fig. 2). These data sug-
gested that STAT1 may be a negative regulator of autophagy 
since the depletion of STAT1 resulted in increased mitochondrial 
turnover.
STAT1 and STAT3 contain conserved LC3-interacting 
motifs
The LC3-interacting region (LIR) is a consensus binding 
motif for the autophagosome forming protein LC3 although 
other binding motifs have been described.33-37 Using protein 
alignments of STAT1 and STAT3 in frog, fish, mouse, rat, and 
human, we found a LIR consensus site that was 100% conserved 
between all species (Fig. 3A). Furthermore, we found additional 
binding motifs which have been described elsewhere further sug-
gesting that STAT1/3 bind to LC3b.37 These motifs were also 
100% conserved with the exception of one which was conserved 
in all species except the frog (Fig. 3A).
The alignments generated above suggested that STAT1 and 
STAT3 were likely candidates for binding to LC3. In order to 
investigate this, we performed co-immunoprecipitation experi-
ments and as shown in Figure 3B, STAT1 co-immunoprecip-
itated LC3b, probably using the LIR motif identified in the 
bioinformatics screen in Figure 3A. We further investigated 
whether STAT3 co-immunoprecipitated with LC3b and found 
that STAT3 did co-precipitate (Fig. 3B).
We next wanted to investigate how STAT1 and STAT3 
behaved following simulated ischemia/reperfusion injury. 
Primary cardiac fibroblasts were subjected to simulated I/R 
Figure 2. hearts from STAT1−/− mice and wild type litter mate controls 
were subjected to ex vivo I/R injury using Langendorff perfusion and 
then sections subjected to electron microscopy. It was found that cells 
from STAT1−/− mice had increased numbers of mitochondria (red arrow) 
located within double membrane structures suggesting they had an 
increased rate of autophagy.
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PINK1 and Parkin mutant cells were also found to have defective 
mitophagy.48 Currently, it is thought that PINK1 phosphorylates 
Parkin which is capable of polyubiquitinating VDAC1 which, 
the induction of mitophagy.36,46,47 Recent data has shown the 
involvement of PTEN-inducing putative kinase-1 (PINK1) and 
the E3-ubiquitin ligase, Parkin, in modulating mitophagy and 
Figure 3. protein alignment of STAT1 and STAT3 sequences with Lc3-interacting regions (LIR) sequences highlighted. Three LIR sequences showed 
100% conservation between STAT1 and STAT1 in human, rat, mouse, frog, and fish (A). The LIR motif YpDI was conserved between STAT1 and STAT3 
in all species except in frog (A). Lc3 was immunoprecipitated from whole cell lysates of cardiomyocytes, run on 10% pAGe gels and western blot 
filters interrogated for STAT1 and STAT3 (B). It was found that STAT1 and STAT-3 co-immunoprecipitated with Lc3 while the pre-immune showed no 
presence of STAT1 or STAT-3 suggesting that the immunoprecipitation was specific (B). primary cardiac fibroblasts were subjected to either control 
(normoxic) conditions or simulated ischemia/reperfusion injury and the mitochondrial and cytosolic fractions isolated. Western blotting for STAT1/3 
revealed STAT1/3 was present in the mitochondrial fraction under control conditions and increased in the cytosolic fraction following I/R injury (C). 
Only a small amount of contamination from the cytosolic fraction was observed as shown by GApDh while no mitochondrial contamination was seen 
in the cytosolic fraction as indicated by coxIV.
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the sternum and dissecting the heart through the chest wall. 
Hearts were washed in isolation buffer (116 mM NaCl, 20 mM 
HEPES, 0.77 mM nNaH
2
PO, 5.5 mM Glucose, 5.4 mM KCl, 
0.4 mM MgSO containing 600 μg/ml Collagenase type II and 
250 μg/ml pancreatin) and cut into small 2 mm pieces then 
incubated at 37 °C in isolation buffer for 15 min with occasional 
agitation and the supernatant spun at 1000× rpm for 5 min. 
The cell pellet was resuspended in 4 ml of fetal bovine serum 
and kept at 37 °C until plating. The digestion procedure was 
repeated 7 times and the pellets pooled and pre-plated for 1 h in 
15% (v/v) FBS in DMEM to remove contaminating fibroblasts. 
Cardiomyocytes were then seeded at 2 × 106 cells per well of a 
6 well plate which had been pre-coated with 2% (w/v) gelatin. 
The DMEM containing 15% (v/v) FBS was replaced the follow-
ing day with maintenance media (DMEM containing 1% [v/v] 
FBS). Fibroblasts obtained from the pre-plating procedure were 
cultured in FBS containing 10% (v/v) DMEM until 80–90% 
before using in downstream experiments.
Simulated ischemia/reperfusion injury
Cell culture media was replaced with ischemic buffer (137 mM 
NaCl, 12 mM KCl, 0.49 mM MgCl
2
, 0.9 mM CaCl
2
·H
2
O, 
4 mM HEPES, 20 mM sodium lactate, and 10 mM deoxyglu-
cose [pH 6.2]) and cells transferred to an ischemic chamber pre-
warmed to 37 °C. Simulated ischemia was achieved by addition 
of 5% CO
2
 in balanced argon to exclude any oxygen. Cells were 
subjected to simulated ischemic injury for 4 h after which isch-
emic buffer was replaced with DMEM containing 1% (v/v) FBS 
and cultured in 5% CO
2
 in air (reperfusion) for the indicated 
times.
Ex vivo ischemia/reperfusion injury
STAT1 knockout (KO) animals were purchased from Taconic 
Farms Inc. and housed under SPF conditions. STAT1 KO ani-
mals (129/Sv) were backcrossed onto a C57B/6 background 
before used in experiments. STAT1 heterozygotes were paired 
to generate KO and wild-type littermate controls which were 
used for the ex vivo studies. Wild-type and STAT1 KO hearts 
from 10 week old male mice were removed and perfused as previ-
ously described.51 Following 20 min of stabilization, hearts were 
exposed to either control or ischemic conditions, then reperfused 
for 45 min. Infarct size was assessed using triphenyl tetrazolium 
chloride staining and computerised planimetry (Planimetry, NIH 
Image 1.63 software package; National Institutes of Health).
Electron microscopy
Electron microscopy was performed on tissue fixed and 
embedded as previously described with minimal modifications.52
Immunofluorescence
Cells were grown on UV irradiated coverslips and fixed in 
4% (w/v) paraformaldehyde in phosphate buffered saline for 15 
min at room temperature. Cells were permeabilized in phosphate 
buffered saline containing 0.1% (v/v) Triton-X100 for 10 min and 
blocked in 5% (w/v) bovine serum albumin in PBS for 30 min. 
Fixed and permeabilized cells were then interrogated with rabbit 
anti-STAT1 (Santa Cruz), mouse anti-STAT1 (Cell Signaling 
Technology), mouse anti-STAT-3 (Cell Signaling Technology), 
and/or mouse anti-LC3b (Abcam) in PBS containing 2.5% (w/v) 
BSA at a 1/1000 dilution for 1 h at room temperature. Cells 
in turn, recruits p62. P62 recruitment binds to ATG8/LC3b at 
the autophagosome, thereby targeting the mitochondria to the 
autophagic pathway.45 These data indicate that the pathway for 
mitochondrial removal by autophagy is indeed very complex and 
so the identification of further proteins involved in this process 
will enable us to not only identify how various cell death/survival 
pathways are interlinked, but importantly allow us to identify 
multiple protein targets which can be exploited for therapy.
In this article we present data suggesting that not only does 
STAT1 appear to localize to the mitochondria but it also seems 
to bind an LC3b binding partner further suggesting a role for 
STAT1 in regulating mitophagy. What remains to be elucidated, 
is the cellular mechanism as to how STAT1 does this. The signal-
ing pathway of autophagy is quite complex and so further studies 
are required to elucidate how STAT1 is involved in regulating 
other proteins to fine tune the autophagic/mitophagic response.
Since STAT1 is a pro-apoptotic protein it is thought that it 
negatively regulates autophagy to facilitate the onset of cell death 
by inhibiting cell survival mechanisms. Similarly, by inhibiting 
mitophagy, the clearance of damaged mitochondria is also inhib-
ited further tipping the balance of cell fate in favor of death. This 
idea is supported by increased numbers of mitochondria located 
in the autophagosomes of STAT1−/− hearts and further by the 
observation of STAT1 localizing to the mitochondria and trans-
locating to the cytosolic fraction following simulated I/R injury. 
This cytosolic translocation of STAT1 would be consistent with 
it becoming localized in autophagosomes.
The accumulation of damaged mitochondria following injury 
is thought to lead to local inflammation and ROS signaling 
resulting in cell death.13 The inhibition of STAT1 may therefore 
present as a potential target for therapy by increasing the rate 
of mitophagy thereby eliminating the accumulation of damaged 
mitochondria and limiting the inflammatory response. Recently, 
Gottlieb and colleagues suggested that dysregulation of mitoph-
agy/autophagy may contribute to primary pathologies such as I/R 
injury and pressure-overload.49 Indeed, release of mitochondrial 
DNA (mtDNA) into the cell is thought to activate the NLRP
3
 
inflammasome leading to IL-1β and IL-18 production.50
In the clinical setting, it has been proposed that the inhibi-
tion of STAT1 may be of benefit in order to reduce the infarct 
area size following myocardial infarction. Since STAT1 has been 
found to negatively regulate autophagy, it would therefore be 
advantageous to inhibit its action to allow the clearance of dam-
aged mitochondria thereby facilitating cell survival.
Materials and Methods
Primary neonatal rat ventricular cardiomyocyte isolation
Primary cardiomyocytes were isolated as previously 
described.17 Animals were housed under SPF conditions and 
sacrificed by schedule 1 killing in accordance to Home Office 
guidelines (Animals for Scientific Procedure Act 1986). All isola-
tion buffers were oxygenated by bubbling medical grade oxygen 
through the solution for 5 min prior to use. Neonate rat pups 
(Sprague-Dawley) that were <2 d postpartum were decapitated 
and rinsed in ethanol. The hearts were removed by cutting along 
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addition of protein A/G sepherose and incubated at 4 °C for 
1 h with rotation. The protein bound beads were then washed 4 
times with ice-cold RIPA buffer and then prepared for western 
blotting.
Western blotting
Cells were lysed in 1× RIPA buffer (20 mM TRIS-HCl [pH 
7.5], 150 mM NaCl, 1 mM EDTA, 1 mM EGTA, 1% [v/v] 
IGEPAL, 1% [w/v] deoxycholate, 250 mM sodium pyrophos-
phate and Complete-mini protease inhibitor cocktail [Roche]) 
and incubated on ice for 15 min. Lysates were passed through 
a 25 gauge needle 5 times and then spun at 13 000 rpm for 5 
min to pellet cell debris. The clarified supernatant was trans-
ferred to a clean tube and assayed for protein using the BCA 
assay kit according to the manufacturer’s instructions (Pierce). 
Twenty micrograms total protein was run on denaturing PAGE 
gels in protein running buffer (25 mM TRIS-HCl, 192 mM 
Glycine, 0.1% [w/v] sodium dodecyl sulfate) and wet-transferred 
in transfer buffer (25 mM TRIS-HCl, 192 mM Glycine, 0.1% 
[w/v] sodium dodecyl sulfate containing 20% [v/v] metha-
nol) to Hybond-C nitrocellulose membrane (GE Healthcare). 
Membranes were blocked for 60 min in 5% (w/v) non-fat dry 
milk in PBS before being interrogated with detection antibodies. 
Primary antibody, rabbit-anti-STAT1 were used at 1/1000 dilu-
tion in 5% (w/v) non-fat dry milk in PBS for 1 h then washed 
3 times in PBS containing 0.1% (v/v) Tween20. Horseradish-
peroxidase conjugated secondary antibodies (DAKO) were used 
at 1/5000 dilution in 5% (w/v) non-fat dry milk for 1 h at room 
temperature then washed 3 times in PBS containing 0.1% (v/v) 
Tween20. Bands were visualized using enhanced chemilumines-
cence (GE Healthcare).
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were washed three times in PBS and then incubated with Alexa-
Fluor secondary antibodies (emission wavelengths Alexa488, 
Alexa546, Molecular Probes). Mitochondria were stained with 
Mitotracker Red (emission 588 nm, Molecular Probes) and cell 
nuclei counter stained with DAPI. Coverslips were mounted onto 
glass slides using fluorescence mounting media (DAKO) and 
images acquired using a Zeiss Axioscope inverted fluorescence 
microscope (Zeiss).
Subcellular fractionation
Subcellular fractionation of mitochondrial and cytosolic frac-
tions was performed using the Qproteome mitochondrial isola-
tion kit (Qiagen). Briefly, cells were washed in 0.9% (w/v) sodium 
chloride and incubated at 4 °C with rotation for 10 min. Cell 
lysates were spun at 1000× g for 10 min and the cytosolic fraction 
stored at −80 °C. The pellet was resuspended in disruption buffer 
and spun at 1000× g and the retained supernatant spun at 6000× 
g to pellet the mitochondria. The supernatant was discarded and 
the pellet resuspended in mitochondria storage buffer then lay-
ered with mitochondrial purification buffer. The mitochondrial 
suspension was spun at 14 000× g and the interphase layer con-
taining the mitochondria was removed. The purified mitochon-
dria were recovered by addition of mitochondrial storage buffer 
and centrifugation at 8000× g to pellet the mitochondria. The 
supernatant was removed and the mitochondrial pellet was stored 
at −80 °C until used in downstream experiments.
Co-immunoprecipitation
Cells were lysed in RIPA buffer (20 mM TRIS-HCl [pH 7.5], 
105 mM NaCl, 1 mM EDTA, 1  mM EGTA, 1% IGEPAL, 1% 
deoxycholate, 250 mM sodium pyrophosphate and Complete-
mini protease inhibitor cocktail [Roche]) for 5 min on ice and 
spun at 13 000× rpm for 5 min and the clarified supernatant 
transferred to a new tube. The protein lysate was pre-cleared 
with protein A/G sepherose (GE Healthcare) for 1 h at 4 °C, 
spun at 3000× rpm to pellet the beads and the pre-cleared super-
natant transferred to a new tube. Ten percent of the lysate was 
removed for the input control, and 3 ug of target antibody added 
and incubated overnight at 4 °C. Proteins were precipitated by 
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